B.C. Trapnell

918 total citations · 1 hit paper
9 papers, 760 citations indexed

About

B.C. Trapnell is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, B.C. Trapnell has authored 9 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in B.C. Trapnell's work include Neonatal Respiratory Health Research (6 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). B.C. Trapnell is often cited by papers focused on Neonatal Respiratory Health Research (6 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). B.C. Trapnell collaborates with scholars based in United States, Germany and Ireland. B.C. Trapnell's co-authors include Keith L. March, Nanette Mittereder, Steven Caras, Susanta Pahari, Mania Ackermann, David Bennett, Adele Mucci, Thomas Moritz, Karen Maguiness and Jean‐Laurent Casanova and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Virology and Stem Cell Reports.

In The Last Decade

B.C. Trapnell

8 papers receiving 743 citations

Hit Papers

Evaluation of the concentration and bioactivity of adenov... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.C. Trapnell United States 4 526 453 212 106 100 9 760
A Jani Canada 8 643 1.2× 729 1.6× 155 0.7× 101 1.0× 102 1.0× 10 955
Dong‐Soo Im South Korea 16 540 1.0× 845 1.9× 232 1.1× 137 1.3× 73 0.7× 30 1.3k
Sean Hofherr United States 14 670 1.3× 624 1.4× 228 1.1× 184 1.7× 42 0.4× 26 938
Christopher R. Logg United States 19 543 1.0× 630 1.4× 273 1.3× 37 0.3× 82 0.8× 27 886
Hideyo Ugai Japan 18 473 0.9× 895 2.0× 216 1.0× 85 0.8× 97 1.0× 47 1.1k
Frits J. Fallaux Netherlands 9 935 1.8× 825 1.8× 379 1.8× 220 2.1× 89 0.9× 16 1.2k
M. Kyle Cromer United States 11 443 0.8× 992 2.2× 255 1.2× 47 0.4× 56 0.6× 17 1.2k
Melinda Van Roey United States 8 450 0.9× 385 0.8× 180 0.8× 60 0.6× 42 0.4× 9 566
Abel Acosta‐Sanchez Belgium 7 560 1.1× 882 1.9× 192 0.9× 54 0.5× 152 1.5× 8 1.2k
Kerstin Sollerbrant Sweden 15 330 0.6× 465 1.0× 118 0.6× 74 0.7× 77 0.8× 19 704

Countries citing papers authored by B.C. Trapnell

Since Specialization
Citations

This map shows the geographic impact of B.C. Trapnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.C. Trapnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.C. Trapnell more than expected).

Fields of papers citing papers by B.C. Trapnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.C. Trapnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.C. Trapnell. The network helps show where B.C. Trapnell may publish in the future.

Co-authorship network of co-authors of B.C. Trapnell

This figure shows the co-authorship network connecting the top 25 collaborators of B.C. Trapnell. A scholar is included among the top collaborators of B.C. Trapnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.C. Trapnell. B.C. Trapnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pahari, Susanta, Anna‐Lena Neehus, B.C. Trapnell, et al.. (2024). Protocol to develop human alveolar macrophage-like cells from mononuclear cells or purified monocytes for use in respiratory biology research. STAR Protocols. 5(2). 103061–103061. 3 indexed citations
2.
Ataya, Ali, et al.. (2024). Pulmonary hypertension during high‐dose GM‐CSF therapy of autoimmune pulmonary alveolar proteinosis. Pulmonary Circulation. 14(4). e70020–e70020.
3.
Trapnell, B.C., Yoshikazu Inoue, Francesco Bonella, et al.. (2024). RCT Abstract - Inhaled molgramostim improves pulmonary gas exchange and respiratory health-related quality of life (HRQoL) in patients with autoimmune pulmonary alveolar proteinosis (aPAP): Results from IMPALA-2. Universitätsbibliographie, Universität Duisburg-Essen. PA5626–PA5626. 1 indexed citations
5.
Platt, Craig D., Sung‐Yun Pai, Lisa R. Forbes, et al.. (2019). STAT5b Deficiency: A Rare Cause of Pulmonary Alveolar Proteinosis. A4935–A4935. 1 indexed citations
6.
Campo, Ilaria, Francesca Mariani, Elena Paracchini, et al.. (2016). Whole Lung Lavage Followed By Inhaled Sargramostim As Therapy Of Autoimmune Pulmonary Alveolar ProteINOSis. American Journal of Respiratory and Critical Care Medicine. 3 indexed citations
7.
Mucci, Adele, Takuji Suzuki, Sebastian Brennig, et al.. (2016). Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency. Stem Cell Reports. 7(2). 292–305. 20 indexed citations
8.
Trapnell, B.C., et al.. (2009). Efficacy and safety of a new formulation of CREON® in patients with exocrine pancreatic insufficiency due to CF. Journal of Cystic Fibrosis. 8. S80–S80. 4 indexed citations
9.
Mittereder, Nanette, Keith L. March, & B.C. Trapnell. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. Journal of Virology. 70(11). 7498–7509. 726 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026